PATENT CLAIM ANALYSIS

Application Number: 15760343
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "211040"]

Abstract:
The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.

Claim (Index 8):
The compound of  claim 7 , wherein each of moieties R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , and R 10  is hydrogen.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 90.0
- Lexical Diversity: 1.17949
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15125911', '15030378', '15566633', '12785665', '15450125']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7744229256287866
- 35 USC 102 Novelty (BERT): 0.5453459122379781
- Combined Prediction Score: 0.7515152242897057
- Mean Citation Score: 318.906982
- Max Citation Score: 380.31046
- Similarity Product: 278.88867631073714

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test